Israel Englander Eli Lilly & CO Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Eli Lilly & CO stock. As of the latest transaction made, Millennium Management LLC holds 425,600 shares of LLY stock, worth $328 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

425,600

Previous 754,708 43.61%

Holding current value

$328 Million

Previous $440 Million 24.74%

% of portfolio

0.15%

Previous 0.19%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $41.2 Million - $55.2 Million	69,615 Added 9.22%	824,323 $641 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $33.6 Million - $39.6 Million	-63,980 Reduced 7.81%	754,708 $440 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $286 Million - $382 Million	815,226 Added 23547.83%	818,688 $384 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $22.9 Million - $26.9 Million	-73,828 Reduced 95.52%	3,462 $1.19 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $84 Million - $97.9 Million	-261,319 Reduced 77.17%	77,290 $28.3 Million

Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $174 Million - $199 Million	-588,486 Reduced 63.48%	338,609 $109 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $147 Million - $173 Million	527,177 Added 131.82%	927,095 $301 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $35.2 Million - $43.8 Million	-150,187 Reduced 27.3%	399,918 $115 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $36.5 Million - $45.3 Million	162,429 Added 41.9%	550,105 $152 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $57 Million - $70.1 Million	257,044 Added 196.77%	387,676 $89.6 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $3.52 Million - $4.56 Million	-19,505 Reduced 12.99%	130,632 $30 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $172 Million - $223 Million	-1,048,442 Reduced 87.47%	150,137 $28 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $19.4 Million - $25.6 Million	148,398 Added 14.13%	1,198,579 $202 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $122 Million - $141 Million	834,266 Added 386.39%	1,050,181 $155 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $26.8 Million - $32.2 Million	196,369 Added 1004.65%	215,915 $35.4 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $31.8 Million - $39.3 Million	-267,023 Reduced 93.18%	19,546 $2.71 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $22.4 Million - $27.7 Million	209,412 Added 271.41%	286,569 $37.7 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $15.6 Million - $16.9 Million	-145,835 Reduced 65.4%	77,157 $8.63 Million
Q2 2019 Aug 15, 2019	BUY	$110.79 - $129.32 $23.7 Million - $27.7 Million	214,279 Added 2459.3%	222,992 $24.7 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $67.1 Million - $78.3 Million	-605,517 Reduced 98.58%	8,713 $750,000
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $98.6 Million - $116 Million	-885,389 Reduced 59.04%	614,230 $79.7 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $73.9 Million - $82.7 Million	697,472 Added 86.95%	1,499,619 $174 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $936,475 - $1.17 Million	10,907 Added 1.38%	802,147 $86.1 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $21.4 Million - $24.5 Million	-282,255 Reduced 26.29%	791,240 $67.5 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $15 Million - $17.7 Million	202,294 Added 23.22%	1,073,495 $83.1 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $56.1 Million - $60.2 Million	684,795 Added 367.37%	871,201 $73.6 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $14.4 Million - $15.9 Million	186,406	186,406 $15.9 Million

Others Institutions Holding LLY

# of Institutions

3,703

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $732B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account